Propionibacterium vector
CA 2331924 A1 · Owner: Luiten, Rudolf Gijsbertus Marie · Inventors: Jore, Johannes Petrus Maria; Pouwels, Pieter Hendrik; Luiten, Rudolf Gijsbertus Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An endogenous plasmid of Propionibacterium is described isolated from , Propionibacteria freudenreichii LMG 16545 (deposited as CBS 101022) and its , sequence provided. This plasmid can be used to transform Propionibacteria to express homologous or heterologous proteins in the production of recombinant , proteins or products of enzymes for example vitamin B12.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 25, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 25, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 25, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.